A novel non-xanthine adenosine A 1 receptor antagonist

Abstract

FK453, (+)-( R)-[( E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl) acryloyl]-2-piperidine ethanol, was examined for adenosine receptor antagonistic activity using isolated guinea-pig atria and aorta and for affinity for adenosine receptors in the rat cerebral cortex and striatum in comparison with FR113452 ( S enantiomer of FK453), PD116948 (1,3-dipropyl-8-cyclopentylxanthine), theophylline (1,3-dimethylxanthine) and CGS15943 ([1,2,4]triazolo[1,5- c]quinazolone). FK453 showed potent inhibition of the negative inotropic activity elicited by 10 μM adenosine with an IC 50 of 560 pM in guinea-pig atria. However, FK453 was less potent in inhibiting the relaxation induced by 3.2 μM adenosine and had an IC 50 of 1.18 μM in guinea-pig aorta. The IC 50 values for FR113452, PD116948, theophylline and CGS15943 were 1.18 μM, 1.31 nM, 20.2 μM and 74.2 nM in atria and > 100 μM, 656 nM, 239 μM, 127 nM in aorta respectively. In the binding study, FK453 antagonized [ 3H] N 6-cyclohexyladenosine binding to the rat cortical adenosine A 1 receptor with an IC 50 of 17.2 nM. The IC 50 values for FR113452, PD116948, theophylline and CGS15943 were 10.1 μM, 4.7 nM, 67.7 μM and 241 nM respectively. FK453 inhibited [ 3H]5′- N-ethylcarboxamideadenosine binding to rat striatum adenosine A 2 receptor with an IC 50 of 11.3 μM. FK453 had no adenosine A 1 receptor agonistic activity, since it had no negative inotropic activity up to 100 μM in isolated guinea-pig atria. These results demonstrate that FK453 is a novel non-xanthine adenosine receptor antagonist and is potent and selective for the adenosine A 1 receptor subtype.